Screener
Fulgent Genetics, Inc. FLGT EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net loss attributable to noncontrolling interests | 448 | 369 |
| Net loss attributable to Fulgent | $(24,826) | $(11,530) |
| Net loss per common share attributable to Fulgent | ||
| Basic | $(0.80) | $(0.37) |
| Diluted | $(0.80) | $(0.37) |
| Weighted-average common shares: | ||
| Basic | 30,881 | 30,832 |
| Diluted | 30,881 | 30,832 |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s EPS (diluted)?
- Fulgent Genetics, Inc. (FLGT) reported EPS (diluted) of -$0.80 in Q1 2026.
- How has Fulgent Genetics, Inc.'s EPS (diluted) changed year-over-year?
- Fulgent Genetics, Inc.'s EPS (diluted) decreased by 116.2% year-over-year, from -$0.37 to -$0.80.
- What is the long-term trend for Fulgent Genetics, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s EPS (diluted) has grown at a -41.2% compound annual growth rate (CAGR), from $16.38 to -$1.96.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Fulgent Genetics, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude